Showing all 6 results

• 
  Clinical research

  ARA-290 (Cibinetide)

  £72.00
  10 mgBatch file pending

  Separates tissue-protective EPO signalling from red-blood-cell production.

  UnavailableAsk about availability
• 
  Preclinical

  BPC-157

  £32.99
  Batch file pending

  BPC-157 is mainly discussed around stomach and local tissue-repair models. TB-500 is instead studied for actin, cell movement…

  Available · 30 in stockAdd to basket
• 
  Preclinical

  BPC-157 + TB-500

  £42.99 – £79.99Price range: £42.99 through £79.99
  5 mg + 5 mg | 10 mg + 10 mgBatch file pending

  The combination places a gastric-peptide-derived experimental material beside an actin-regulatory thymosin pathway, rather than combining two versions of…

  AvailableAdd to basket This product has multiple variants. The options may be chosen on the product page
• 
  Experimental

  Cartalax

  £46.00
  20 mgBatch file pending

  Cartilage-cell focus, rather than BPC-157’s broader repair signalling or GHK-Cu’s collagen/copper biology.

  UnavailableAsk about availability
• 
  Preclinical

  TB-500

  £32.99
  Batch file pending

  TB-500 is discussed as a fragment-like repair material, while thymosin beta-4 is the full natural protein and BPC-157…

  Available · 30 in stockAdd to basket
• 
  Early human evidence

  Thymosin Beta-4

  £62.00
  10 mgBatch file pending

  Full-length endogenous thymosin beta-4 with broader actin biology, rather than the shorter TB-500-style material.

  UnavailableAsk about availability